This holiday season, consider incorporating cannabis into your family gatherings as a natural way to manage stress and promote a more peaceful atmosphere. Learn how microdosing THC gummies can help you stay calm, relaxed, and engaged with loved ones, even during potentially tense conversations.
This article explores the evolving landscape of cannabis regulations around the world, highlighting significant changes in Poland, Thailand, Japan, and Australia. From stricter access to medical marijuana in Poland to ultra-strict THC limits in Japan, the article examines the various approaches countries are taking towards cannabis use.
Tenet Healthcare Corporation (THC) exceeded analysts’ expectations in the third quarter, reporting robust revenue growth and strong profitability. The company’s focus on strategic execution and disciplined operations has driven same-store revenue growth and profitability, resulting in a significant increase in free cash flow. This strong performance has led to an upward revision in the company’s full-year revenue and earnings guidance, and its stock price surged over 12% in response.
New York’s Office of Cannabis Management (OCM) has ordered a halt to the sale of caffeine-infused THC products by Hudson Cannabis, sparking controversy and raising questions about regulatory consistency. While the OCM cites public health concerns, industry experts argue that the products are safe and legally sold in other states. This ban highlights the evolving landscape of cannabis regulation and the challenges of balancing public safety with innovation.
The FDA’s recent decision to impose a 2 ppm THC limit on hemp meal for animal feed is sparking controversy, drawing criticism for its lack of scientific justification and its potential to stifle the burgeoning hemp industry. This article delves into the history of the FDA’s relationship with hemp, explores the double standards in regulation, and argues for a science-based approach to hemp regulation.
A comprehensive review of existing research has revealed limited evidence for a direct correlation between blood THC levels and driving ability. While the study highlights the complexity of evaluating driving impairment, it emphasizes the need for further research to understand the impact of cannabis use on driving performance under various real-world conditions.
Louisiana’s hemp industry is facing a legal challenge over a new state law that restricts THC levels in hemp products. Businesses and farmers argue that the law violates federal standards and could severely impact the state’s growing hemp market. This legal battle mirrors similar disputes nationwide, highlighting the complex regulatory landscape for hemp products.
Ascend Wellness Holdings, a vertically integrated cannabis operator, announced the launch of its new edibles-only brand, ‘Effin’. The brand focuses on delivering specific effects through expertly formulated combinations of THC and minor cannabinoids. Effin’ initially debuted in Massachusetts and Illinois and is set to launch in New Jersey soon, offering unique SKUs targeting chill, sleep, focus, and energy.
Washington State University researchers have received a $670,000 grant from the National Institutes of Health (NIH) to address cannabis misuse among young adults, particularly focusing on the risks associated with edibles. The project, led by Stacey Hust and Jessica Willoughby, will develop and test a technology-based intervention to educate college students in Washington, Illinois, and New York.
Recent research has unveiled the potential anticancer properties of cannabinoids like THC, CBD, and CBG, sparking optimism for their role in inhibiting tumor growth and improving palliative care. However, despite promising findings, challenges remain in understanding their mechanisms and translating these discoveries into effective clinical applications. The article explores the potential benefits, research gaps, and regulatory hurdles hindering wider adoption of cannabinoids in cancer treatment.
